Dorrit Andersen is responsible for the regulatory affairs activities as a consultant. She has more than 30 years of experience in the biopharmaceutical industry working with global development of pharmaceuticals (quality, clinical and regulatory). Dorrit has previously worked as global regulatory affairs director at Novo Nordisk and before establishing her consultancy business as regulatory affairs manager at Symphogen and Genmab. Prior to Novo Nordisk she was head of regulatory affairs and clinical project manager at Ciba-Geigy DK. Her latest accomplishment as a consultant is the submission and approval of a recombinant protein therapeutic in the USA and EU. Dorrit Andersen holds a degree in pharmacy from the University of Copenhagen.
Pharmaceuticals